Diazyme's Lipoprotein (a) Lp(a) is a dual vial, liquid stable reagent system which provides reliable results. The Lp(a) assay features time saving instrument specific packaging options which eliminate reagent transfer and increases operator efficiency. The assay method requires only 6 μL of serum sample and is completed in less than 10 minutes. Diazyme’s Lp(a) has excellent correlation with existing commercial products with a correlation coefficient of 0.9868, slope of 0.9828, and y intercept of 1.0033. Lp(a)’s linear range extends up to 100 mg/dL and has Within-Run and Between-Run precision CV values ≤ 3.7%.
The Diazyme Lp(a) Assay is based on a latex enhanced immunoturbidimetric assay. Lp(a) in the sample binds to specific anti- Lipoprotein (a) antibody, which is coated on latex particles, and causes agglutination. The degree of the turbidity caused by agglutination can be measured optically and is proportional to the amount of Lipoprotein (a) in the sample.
The Diazyme Lp(a) Assay is intended as a latex particle enhanced immunoturbidimetric assay for the in vitro quantitative determination of Lp(a) concentration in human serum or plasma on Clinical Chemistry Systems. The measurement of Lipoprotein (a) is useful in evaluating lipid metabolism disorders and assessing atherosclerotic cardiovascular diseases in specific populations, when used in conjunction with clinical evaluation. For in vitro diagnostic use only.
|Kit||DZ131B||R1/R2 (Dual Vial Liquid Stable)||Dual Vial Liquid Stable, |
|Calibrator||DZ131B-CAL||Cal: 5 Level (Lyophilized)|| |
|Control||DZ131B-CON||Con: 2 Level (Lyophilized)|| |